| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Howard L. Weiner | Q20985921 |
| P2093 | author name string | Alice Laroni | |
| Roopali Gandhi | |||
| P2860 | cites work | Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis | Q80089503 |
| Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells | Q80154712 | ||
| Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response | Q80209390 | ||
| Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis | Q80363030 | ||
| Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta | Q80551920 | ||
| In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses | Q80918088 | ||
| Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease | Q81077809 | ||
| EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity | Q81317223 | ||
| Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis | Q81342560 | ||
| Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen | Q81434908 | ||
| Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis | Q81474077 | ||
| Immunology of multiple sclerosis | Q81531267 | ||
| Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism | Q81621858 | ||
| Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis | Q81733254 | ||
| Human mast cells stimulate activated T cells: implications for multiple sclerosis | Q82934524 | ||
| IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production | Q24338636 | ||
| Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation | Q24644706 | ||
| Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells | Q24675226 | ||
| [gamma][delta] cells: a right time and a right place for a conserved third way of protection | Q28145655 | ||
| NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor | Q28241325 | ||
| Natural killer type 2 bias in remission of multiple sclerosis | Q28359878 | ||
| Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis | Q28591514 | ||
| The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| Th17 cells: effector T cells with inflammatory properties | Q33732092 | ||
| Mast cells in allergy: innate instructors of adaptive responses | Q34004510 | ||
| Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells | Q34062282 | ||
| Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease | Q34112417 | ||
| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Dendritic cells: immune regulators in health and disease | Q34482541 | ||
| Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. | Q34596171 | ||
| Toll-Like Receptors and Inflammation in the CNS | Q35560638 | ||
| Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis | Q35829642 | ||
| Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease | Q35914863 | ||
| New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. | Q35976729 | ||
| Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis | Q36081667 | ||
| Natural-killer cells and dendritic cells: "l'union fait la force". | Q36149272 | ||
| Dendritic cells prime natural killer cells by trans-presenting interleukin 15 | Q36157184 | ||
| Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo | Q36365201 | ||
| Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | Q36369797 | ||
| Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 | ||
| Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis | Q36375991 | ||
| Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells | Q36380889 | ||
| Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis | Q36403957 | ||
| Effector and regulatory events during natural killer-dendritic cell interactions | Q36652210 | ||
| Activation of natural killer T cells by glycolipids | Q36667114 | ||
| Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis | Q36766158 | ||
| NK cells at the interface between innate and adaptive immunity | Q36836620 | ||
| Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up | Q48335818 | ||
| Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. | Q48461850 | ||
| The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system | Q48554549 | ||
| Mast cells in plaques of multiple sclerosis | Q48609684 | ||
| Peripheral blood ?-? T cells lyse fresh human brain?Derived oligodendrocytes | Q48613619 | ||
| Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis | Q48652496 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury | Q48822291 | ||
| Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains | Q48846971 | ||
| Mast cell activation by myelin through scavenger receptor | Q49034996 | ||
| A role for natural killer cells in the immunopathogenesis of multiple sclerosis. | Q50876710 | ||
| Differentiation of human NK cells into NK1 and NK2 subsets. | Q52036591 | ||
| NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. | Q52576677 | ||
| Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. | Q52937746 | ||
| CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
| Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis. | Q54269703 | ||
| Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. | Q54523448 | ||
| Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses | Q56988858 | ||
| Innate immune-mediated neuronal injury consequent to loss of astrocytes | Q57041709 | ||
| Immunity or tolerance? That is the question for dendritic cells | Q57227901 | ||
| Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines | Q62065049 | ||
| A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse | Q71384783 | ||
| Gamma delta T cell receptor variable region usage during the development of experimental allergic encephalomyelitis | Q71586060 | ||
| Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination | Q71610031 | ||
| Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody | Q73128587 | ||
| NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance | Q73311779 | ||
| Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells | Q73311971 | ||
| Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma | Q73540137 | ||
| Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy | Q73644565 | ||
| Cytokines: influence on glial cell gene expression and function | Q73837328 | ||
| Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo | Q77323598 | ||
| Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide | Q77703439 | ||
| Mature bone marrow-derived dendritic cells polarize Th2 response and suppress experimental autoimmune encephalomyelitis | Q78637162 | ||
| Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission | Q78961005 | ||
| Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity | Q79329740 | ||
| Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo | Q79929612 | ||
| Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. | Q46078718 | ||
| A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis | Q46875995 | ||
| Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis | Q46973046 | ||
| The regulatory role of natural killer cells in multiple sclerosis | Q47260618 | ||
| Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production | Q47309507 | ||
| FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. | Q47391978 | ||
| Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course | Q47581695 | ||
| Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis | Q47817717 | ||
| The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors | Q47871181 | ||
| The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. | Q47936770 | ||
| Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis | Q48035765 | ||
| Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. | Q48074043 | ||
| Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis | Q48100149 | ||
| Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. | Q48176320 | ||
| Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis | Q48218333 | ||
| The multitasking mast cell: positive and negative roles in the progression of autoimmunity | Q36914685 | ||
| Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases | Q36976323 | ||
| Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition | Q37001277 | ||
| Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals | Q37003800 | ||
| Toll-like receptors in defense and damage of the central nervous system | Q37015536 | ||
| NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi | Q37018981 | ||
| Role of natural killer cells in the pathogenesis and progression of multiple sclerosis | Q37053278 | ||
| A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis | Q37101287 | ||
| Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis | Q37121507 | ||
| Induction and effector functions of T(H)17 cells. | Q37194494 | ||
| Microglial clearance function in health and disease | Q37222916 | ||
| Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis | Q37243469 | ||
| Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells | Q37313533 | ||
| NK cells and Treg cells: a fascinating dance cheek to cheek | Q37315670 | ||
| Regulation of autoimmune encephalomyelitis by toll-like receptors | Q37390942 | ||
| The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? | Q37427659 | ||
| Protective effects of microglia in multiple sclerosis. | Q37467153 | ||
| Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis | Q37555960 | ||
| Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. | Q38495710 | ||
| Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions | Q39821466 | ||
| Production and functions of IL-17 in microglia | Q40029522 | ||
| Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
| Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. | Q40460778 | ||
| Characterization of human blood dendritic cell subsets | Q40625943 | ||
| Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. | Q40869638 | ||
| Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene | Q40911408 | ||
| Targeting of human dendritic cells by autologous NK cells. | Q40914002 | ||
| Mast cells in the brain: evidence and functional significance. | Q41095954 | ||
| gamma delta T-cell-human glial cell interactions. II. Relationship between heat shock protein expression and susceptibility to cytolysis | Q41119043 | ||
| gamma delta T-cell-human glial cell interactions. I. In vitro induction of gammadelta T-cell expansion by human glial cells | Q41119050 | ||
| Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells | Q41139248 | ||
| Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. | Q41985283 | ||
| Reciprocal activating interaction between natural killer cells and dendritic cells | Q41992239 | ||
| Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells | Q42005335 | ||
| Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients | Q42280284 | ||
| Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia. | Q42518403 | ||
| Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset | Q43600819 | ||
| The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation | Q43819984 | ||
| CD4+, CD8+, and CD4- CD8- T cells in CSF and blood of patients with multiple sclerosis and tension headache | Q44262356 | ||
| Broad expression of Toll-like receptors in the human central nervous system | Q44492400 | ||
| Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis | Q44701314 | ||
| Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis | Q44820890 | ||
| The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells | Q44910149 | ||
| Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity | Q44916817 | ||
| Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice | Q45740050 | ||
| Natural history of multiple sclerosis in a population-based cohort | Q45767634 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| multiple sclerosis | Q8277 | ||
| P304 | page(s) | 7-14 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Role of the innate immune system in the pathogenesis of multiple sclerosis | |
| P478 | volume | 221 |
| Q37144048 | 11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats |
| Q36557899 | 12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis |
| Q38078463 | A Sardinian map for multiple sclerosis |
| Q92640062 | Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients |
| Q90703951 | Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain |
| Q36062897 | Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process |
| Q42361890 | Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world |
| Q40732094 | Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis |
| Q55244957 | Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation. |
| Q37971896 | Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis |
| Q28741088 | Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patients |
| Q36764500 | Autophagy and autoimmunity crosstalks |
| Q36031145 | Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce. |
| Q38324480 | Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. |
| Q39844505 | Characterization of brain lesions in a mouse model of progressive multiple sclerosis |
| Q26774368 | Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis |
| Q38946338 | Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion. |
| Q37945301 | Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? |
| Q91576425 | Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity |
| Q41605897 | Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler's Murine Encephalomyelitis |
| Q47883172 | Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes |
| Q89999379 | Epidemiology and treatment of multiple sclerosis in elderly populations |
| Q52597663 | Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography. |
| Q89820664 | Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis |
| Q37765473 | Fingolimod is a potential novel therapy for multiple sclerosis |
| Q44727156 | Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells |
| Q54375281 | Fungal infection in a patient with multiple sclerosis. |
| Q85093792 | Getting to grips with myelin injury in progressive multiple sclerosis |
| Q34624054 | Gut microbiome and the risk factors in central nervous system autoimmunity. |
| Q36374681 | H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis |
| Q38798523 | Host and Environmental Factors Influencing Individual Human Cytokine Responses |
| Q47802205 | Immunomodulatory Effects of Adipose Stromal Vascular Fraction Cells Promote Alternative Activation Macrophages to Repair Tissue Damage. |
| Q26745562 | Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology |
| Q36957280 | Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation |
| Q45463857 | In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed. |
| Q33558399 | In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis |
| Q35061290 | Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients |
| Q91137019 | Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss |
| Q38186205 | Infections and multiple sclerosis |
| Q36597282 | Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis |
| Q34670542 | Inflammasomes and autoimmunity |
| Q38156767 | Initial immunopathogenesis of multiple sclerosis: innate immune response. |
| Q60920839 | Innate Immunity Cells and the Neurovascular Unit |
| Q26765847 | Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases |
| Q37882071 | Innate immune responses in central nervous system inflammation |
| Q26765787 | Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases |
| Q38068379 | Is the CCR5 Δ 32 mutation associated with immune system-related diseases? |
| Q59349868 | KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects |
| Q35156771 | Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord |
| Q47719110 | Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis. |
| Q38007884 | Mast cells: an expanding pathophysiological role from allergy to other disorders |
| Q37599583 | Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis |
| Q37824264 | MicroRNAs and Multiple Sclerosis |
| Q38132114 | MicroRNAs as novel regulators of neuroinflammation |
| Q36995320 | Microglia play a major role in direct viral-induced demyelination |
| Q38527788 | Microvesicles: What is the Role in Multiple Sclerosis? |
| Q37590908 | Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. |
| Q43136157 | Multiple sclerosis and the blood-central nervous system barrier |
| Q38254152 | Multiple sclerosis and the role of immune cells. |
| Q21558407 | Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone |
| Q37601317 | Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models |
| Q38130445 | Multiple sclerosis: basic knowledge and new insights in perioperative management |
| Q35151851 | Multiple sclerosis: pathogenesis and treatment |
| Q34713974 | Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study. |
| Q41615056 | Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis |
| Q37690952 | Natural killer cells in human autoimmune disorders |
| Q38684679 | Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation |
| Q38114139 | Neurosteroids and epileptogenesis. |
| Q92483991 | Opposing T cell responses in experimental autoimmune encephalomyelitis |
| Q38863622 | Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12. |
| Q38096246 | Polarization of macrophages and microglia in inflammatory demyelination |
| Q34296297 | Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis |
| Q28078621 | Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes |
| Q34117630 | ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex. |
| Q48253824 | Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide |
| Q36271903 | Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis |
| Q39032832 | Regulatory Functions of Natural Killer Cells in Multiple Sclerosis. |
| Q39057292 | Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q38495280 | Selenium, selenoproteins and neurodegenerative diseases. |
| Q35922211 | Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility |
| Q47095705 | Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey |
| Q40189763 | Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action |
| Q37859376 | Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy. |
| Q24297472 | Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L |
| Q52668328 | Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. |
| Q37990779 | Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. |
| Q28076400 | The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis |
| Q42617618 | The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases. |
| Q24597958 | The innate immune system in demyelinating disease |
| Q50671084 | The role of Candida albicans in the severity of multiple sclerosis. |
| Q39442839 | The role of microglia in multiple sclerosis. |
| Q38089599 | The role of natural killer cells in multiple sclerosis and their therapeutic implications |
| Q35016997 | The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis |
| Q33851359 | Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. |
| Q37880364 | Toll-like receptors are key players in neurodegeneration |
| Q38098448 | Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system |
| Q36500155 | Upregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis |
| Q37932867 | Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study |
| Q38809547 | What rheumatologists need to know about innate lymphocytes |
| Q33781574 | White matter damage and systemic inflammation in Parkinson's disease |
Search more.